September 29, 2025
Elite Diagnostic Limited(ELITE)
Audited financials for the twelve months ended June 30, 2025:
Elite Diagnostic Limited (ELITE) for the twelve months ended June 30, 2025 reported a 4% increase in Income totaling $853.82 million compared to $821.28 million in the corresponding period last year. Income for the fourth quarter had an 8% decrease to close at $225.01 million compared to $244.18 million for the comparable quarter of 2024.
Direct costs amounted to $211.44 million (2024: $233.62 million), this represents a decrease of 9% year over year. Consequently, gross profit increased by 9% to $642.39 million compared to $587.66 million for the twelve months ended June 30, 2024. The company booked gross profit of $172.85 million for the fourth quarter versus $176.28 million reported for the similar quarter of 2024.
Administrative expenses increased by 12% to close at $400.90 million (2024: $355.89 million), while Depreciation & Amortization increased by 26% from $135.23 million in 2024 to $170.11 million in the period under review. Additionally, Impairment credit amounted to $1.93 million (2024: Impairment loss of $1.18 million). As a result, operating profit for the twelve months ended June 30, 2025, amounted to $73.31 million, a 23% decrease relative to $95.37 million reported in 2024.
Foreign Gain for the twelve months ended June 30, 2025, amounted to $2.62 million (2024: Loss of $3.32 milllion). Finance Cost totaled $39.14 million, a 38% decrease from the corresponding period last year. (2024: $62.79 million).
Profit Before Tax for the twelve months ended June 30, 2025, amounted to $36.92 million, a 26% increase relative to $29.35 million reported in 2024. Profit Before Tax for the fourth quarter amounted to $27.77 million (2024: $33.88 million).
The tax charge incurred for the twelve months ended June 30, 2025, had a 53% increase to reach $4.90 million (2024: $3.19 million). As a result, Net Profit for the twelve months amounted to $32.02 million, a 22% increase from the $26.15 million reported in 2024. For the fourth quarter, Net Profit was $23.35 million (2024: $32.75 million).
Consequently, Earnings Per Share for the twelve months amounted to $0.09 (2024: EPS: $0.07), while Earnings Per Share for the quarter totaled $0.07 (2024: EPS: $0.09). The number of shares used in these calculations was 353,400,000.
Notably, ELITE’s stock price closed the trading period on September 26, 2025 at a price of $1.53 with a corresponding P/E ratio of 16.77x.
Balance Sheet Highlights
The company’s assets totalled $1.11 billion (2024: $1.06 billion). The movement in total assets was mainly attributable to 506% increase in ‘Cash and cash equivalents’ amounting to $225.55 million (2024: $37.22 million), which was offset by a 46.39 million decline in ‘Property, plant and equipment’ amounting to $701.16 million (2024: $747.54 million)
Shareholders’ equity was $543.01 million (2024: $510.98 million), representing a book value per share of $1.54 (2024: $1.45).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.